CoChat

Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription

Open access
Gao, Rui, Chakraborty, Anirban, Geater, Charlene, Pradhan, Subrata, Gordon, Kara L, Snowden, Jeffrey, Yuan, Subo, Dickey, Audrey S, Choudhary, Sanjeev, Ashizawa, Tetsuo, Ellerby, Lisa M, La Spada, Albert R, Thompson, Leslie M, Hazra, Tapas K, Sarkar, Partha S · 2019 · eLife
Cited by 119

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

How huntingtin (HTT) triggers neurotoxicity in Huntington’s disease (HD) remains unclear. We report that HTT forms a transcription-coupled DNA repair (TCR) complex with RNA polymerase II subunit A (POLR2A), ataxin-3, the DNA repair enzyme polynucleotide-kinase-3'-phosphatase (PNKP), and cyclic AMP-response element-binding (CREB) protein (CBP). This complex senses and facilitates DNA damage repair during transcriptional elongation, but its functional integrity is impaired by mutant HTT. Abrogated PNKP activity results in persistent DNA break accumulation, preferentially in actively transcribed genes, and aberrant activation of DNA damage-response ataxia telangiectasia-mutated (ATM) signaling in HD transgenic mouse and cell models. A concomitant decrease in Ataxin-3 activity facilitates CBP ubiquitination and degradation, adversely impacting transcription and DNA repair. Increasing PNKP activity in mutant cells improves genome integrity and cell survival. These findings suggest a potential molecular mechanism of how mutant HTT activates DNA damage-response pro-degenerative pathways and impairs transcription, triggering neurotoxicity and functional decline in HD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7554/elife.42988

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 50

  1. Bae, 2005, p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease, Neuron, 47, 29, 10.1016/j.neuron.2005.06.005 · DOI · Paper page
  2. Bertoni, 2011, Early and late events induced by polyQ-expanded proteins: identification of a common pathogenic property of polYQ-expanded proteins, The Journal of Biological Chemistry, 286, 4727, 10.1074/jbc.M110.156521 · DOI · Paper page
  3. Bettencourt, 2016, DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases, Annals of Neurology, 79, 983, 10.1002/ana.24656 · DOI · Paper page
  4. Burnett, 2003, The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity, Human Molecular Genetics, 12, 3195, 10.1093/hmg/ddg344 · DOI · Paper page
  5. Chai, 2004, Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways, Journal of Biological Chemistry, 279, 3605, 10.1074/jbc.M310939200 · DOI · Paper page
  6. Chakraborty, 2015, Neil2-null mice accumulate oxidized DNA bases in the transcriptionally active sequences of the genome and are susceptible to innate inflammation, Journal of Biological Chemistry, 290, 24636, 10.1074/jbc.M115.658146 · DOI
  7. Chakraborty, 2016, Classical non-homologous end-joining pathway utilizes nascent RNA for error-free double-strand break repair of transcribed genes, Nature Communications, 7, 10.1038/ncomms13049 · DOI · Paper page
  8. Chatterjee, 2015, The role of the mammalian DNA End-processing enzyme polynucleotide kinase 3’-Phosphatase in Spinocerebellar Ataxia Type 3 Pathogenesis, PLOS Genetics, 11, 10.1371/journal.pgen.1004749 · DOI
  9. Cong, 2005, Mutant huntingtin represses CBP, but not p300, by binding and protein degradation, Molecular and Cellular Neuroscience, 30, 12, 10.1016/j.mcn.2005.05.003 · DOI
  10. Dunah, 2002, Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease, Science, 296, 2238, 10.1126/science.1072613 · DOI · Paper page
  11. Gao, 2015, Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3, PLOS Genetics, 11, 10.1371/journal.pgen.1004834 · DOI
  12. Giralt, 2012, Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity, Human Molecular Genetics, 21, 1203, 10.1093/hmg/ddr552 · DOI · Paper page
  13. Giuliano, 2003, DNA damage induced by polyglutamine-expanded proteins, Human Molecular Genetics, 12, 2301, 10.1093/hmg/ddg242 · DOI
  14. Hanawalt, 2008, Transcription-coupled DNA repair: two decades of progress and surprises, Nature Reviews Molecular Cell Biology, 9, 958, 10.1038/nrm2549 · DOI · Paper page
  15. Huang, 1998, Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins, Somatic Cell and Molecular Genetics, 24, 217, 10.1023/B:SCAM.0000007124.19463.e5 · DOI · Paper page
  16. Igarashi, 2003, Inducible PC12 cell model of Huntington’s disease shows toxicity and decreased histone acetylation, Mol Neuroscience, 14, 565, 10.1097/01.wnr.0000062604.01019.e1 · doi:10.1097/01.wnr.0000062604.01019.e1
  17. Illuzzi, 2009, DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates, Journal of Neuroscience Research, 87, 733, 10.1002/jnr.21881 · DOI · Paper page
  18. Jiang, 2003, Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein, Human Molecular Genetics, 12, 1, 10.1093/hmg/ddg002 · DOI · Paper page
  19. Jimenez-Sanchez, 2017, Huntington’s disease: Mechanisms of pathogenesis and therapeutic strategies, Cold Spring Harbor Perspectives in Medicine, 2017, 10.1101/cshperspect.a024240 · DOI · Paper page
  20. Karimi-Busheri, 1999, Molecular characterization of a human DNA kinase, Journal of Biological Chemistry, 274, 24187, 10.1074/jbc.274.34.24187 · DOI · Paper page
  21. Kumar, 2014, Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis, Drug Discovery Today, 19, 956, 10.1016/j.drudis.2014.03.016 · DOI · Paper page
  22. Li, 1995, A huntingtin-associated protein enriched in brain with implications for pathology, Nature, 378, 398, 10.1038/378398a0 · DOI · Paper page
  23. Luthi-Carter, 2003, Mechanisms of transcriptional dysregulation in Huntington's disease, Clinical Neuroscience Research, 3, 165, 10.1016/S1566-2772(03)00059-8 · DOI
  24. MACDONALD, 1993, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes, Cell, 72, 971, 10.1016/0092-8674(93)90585-E · DOI · Paper page
  25. Mandal, 2012, Role of human DNA glycosylase Nei-like 2 (NEIL2) and single strand break repair protein polynucleotide kinase 3'-phosphatase in maintenance of mitochondrial genome, Journal of Biological Chemistry, 287, 2819, 10.1074/jbc.M111.272179 · DOI · Paper page
  26. McCampbell, 2000, CREB-binding protein sequestration by expanded polyglutamine, Human Molecular Genetics, 9, 2197, 10.1093/hmg/9.14.2197 · DOI · Paper page
  27. Menalled, 2012, Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175, PLOS ONE, 7, 10.1371/journal.pone.0049838 · DOI · Paper page
  28. Nucifora, 2001, Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity, Science, 291, 2423, 10.1126/science.1056784 · DOI · Paper page
  29. Olive, 2006, The comet assay: a method to measure DNA damage in individual cells, Nature Protocols, 1, 23, 10.1038/nprot.2006.5 · DOI · Paper page
  30. Orr, 2008, N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking, Journal of Neuroscience, 28, 2783, 10.1523/JNEUROSCI.0106-08.2008 · DOI · Paper page
  31. Poulton, 2013, Progressive cerebellar atrophy and polyneuropathy: expanding the spectrum of PNKP mutations, Neurogenetics, 14, 43, 10.1007/s10048-012-0351-8 · DOI
  32. Ross, 2011, Huntington's disease: from molecular pathogenesis to clinical treatment, The Lancet Neurology, 10, 83, 10.1016/S1474-4422(10)70245-3 · DOI · Paper page
  33. Sailaja, 2012, Chromatin immunoprecipitation in mouse hippocampal cells and tissues, Methods in Molecular Biology, 809, 353, 10.1007/978-1-61779-376-9_24 · DOI
  34. Santos, 2006, Quantitative PCR-based measurement of nuclear and mitochondrial DNA damage and repair in mammalian cells, Methods in Molecular Biology, 314, 183, 10.1385/1-59259-973-7:183 · DOI · Paper page
  35. Schilling, 1999, Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin, Human Molecular Genetics, 8, 397, 10.1093/hmg/8.3.397 · DOI · Paper page
  36. Schmitt, 2007, Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination, Biochemical and Biophysical Research Communications, 362, 734, 10.1016/j.bbrc.2007.08.062 · DOI · Paper page
  37. Shen, 2010, Mutations in PNKP cause microcephaly, seizures and defects in DNA repair, Nature Genetics, 42, 245, 10.1038/ng.526 · DOI · Paper page
  38. Shirendeb, 2011, Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage, Human Molecular Genetics, 20, 1438, 10.1093/hmg/ddr024 · DOI · Paper page
  39. Siddiqui, 2012, Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease, Free Radical Biology and Medicine, 53, 1478, 10.1016/j.freeradbiomed.2012.06.008 · DOI · Paper page
  40. Steffan, 2000, The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription, PNAS, 97, 6763, 10.1073/pnas.100110097 · DOI · Paper page
  41. Suhr, 2001, Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression, The Journal of Cell Biology, 153, 283, 10.1083/jcb.153.2.283 · DOI · Paper page
  42. Takeshita, 2011, Interaction of ataxin-3 with huntingtin-associated protein 1 through josephin domain, NeuroReport, 22, 232, 10.1097/WNR.0b013e32834505f4 · doi:10.1097/wnr.0b013e32834505f4
  43. Tanaka, 2006, Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin, Neurobiology of Disease, 21, 381, 10.1016/j.nbd.2005.07.014 · DOI
  44. Telezhkin, 2016, Forced cell cycle exit and modulation of GABAA, CREB, and GSK3β signaling promote functional maturation of induced pluripotent stem cell-derived neurons, American Journal of Physiology-Cell Physiology, 310, C520, 10.1152/ajpcell.00166.2015 · DOI
  45. Valor, 2015, Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective, Molecular Neurobiology, 51, 406, 10.1007/s12035-014-8715-8 · DOI
  46. Vonsattel, 1998, Huntington disease, Journal of Neuropathology and Experimental Neurology, 57, 369, 10.1097/00005072-199805000-00001 · DOI · Paper page
  47. Wiederhold, 2004, AP endonuclease-independent DNA base excision repair in human cells, Molecular Cell, 15, 209, 10.1016/j.molcel.2004.06.003 · DOI · Paper page
  48. Wyttenbach, 2001, Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease, Human Molecular Genetics, 10, 1829, 10.1093/hmg/10.17.1829 · DOI · Paper page
  49. Xh, 2014, Targeting ATM ameliorates mutant huntingtin toxicity in cell and animal models of Huntington’s disease, Science Translational Medicine, 268, 10.1126/scitranslmed.3010523 · DOI · Paper page
  50. Zhai, 2005, In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets, Cell, 123, 1241, 10.1016/j.cell.2005.10.030 · DOI · Paper page

Cited by

See all 119

Metadata

Authors
Gao, R., Chakraborty, A., Geater, C., Pradhan, S., Gordon, K. L., Snowden, J., Yuan, S., Dickey, A. S., Choudhary, S., Ashizawa, T., Ellerby, L. M., La Spada, A. R., Thompson, L. M., Hazra, T. K., & Sarkar, P. S.
Venue
eLife
Published
2019-04-17
Volume
8
ISSN
2050-084X (ISSN-L)
OpenAlex
W2936437073
Cited by
119
References
10
FWCI
6.17
Type
journal article
Language
en
Open access
gold
Funders
  • NIH Office of the Director (NSO79541-01, EY026089-01A1, NS100529, AG033082, NS065874, NS089076, NS090390, NS073976)
  • Hereditary Disease Foundation (Postdoctoral Fellowship)
  • Mitchel Center for Neurodegenerative Diseases, University of Texas Medical Branch (Intramural Developmental Grant)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription. https://app.cochat.ai/papers/10.7554/elife.42988
The paper
Gao, R., Chakraborty, A., Geater, C., Pradhan, S., Gordon, K. L., Snowden, J., Yuan, S., Dickey, A. S., Choudhary, S., Ashizawa, T., Ellerby, L. M., La Spada, A. R., Thompson, L. M., Hazra, T. K., & Sarkar, P. S. (2019). Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription. eLife. https://doi.org/10.7554/elife.42988

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.